5 concerns over multiple cancer PBS listings

Should the rules for cancer patients on checkpoint inhibitors be different from anyone else?

Patient and drug company pressure to allow multiple cancer listings to be made at once for checkpoint inhibitors seems unlikely to be realised, with the release of a new PBAC report.